Back

From clinical to multimodality imaging: red flags in cardiac amyloidosis diagnosis.

9 December 2021 (14:20 - 14:30)
Organised by:
Congress Presentation Part of: Management of cardiac amyloid guided by multimodality imaging: the paradigm has shifted Cross-Modality and Multi-Modality Imaging Topics, Other EACVI Premium Access EuroEcho 2021

About the speaker

Photo
Doctor Prem Soman

Upmc University Of Pittsburgh Medical Center, Pittsburgh (United States of America)

3 More presentations in this session

Presentation thumbnail
Imaging to define cardiac amyloidosis prognosis: practical implications.
Doctor S. Dorbala (Boston, US)
Slides Video
Presentation thumbnail
Imaging endpoints in cardiac amyloidosis therapy: current state and future outlook.
Professor M. Fontana (London, GB)
Slides Video
Presentation thumbnail
Management of cardiac amyloid guided by multimodality imaging: the paradigm has shifted - discussion.
Video

Access the full session

Session thumbnail
Management of cardiac amyloid guided by multimodality imaging: the paradigm has shifted
Video

The Event

Event poster

EuroEcho 2021

9 December 2021 14:20 CET
You may be interested in
thumbnail
Congress Session
Amyloidosis - it never comes alone?
18 May 2025
thumbnail
Congress Presentation
Red-flag signs and symptoms of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy in the TTRACK study
21 May 2023
thumbnail
Congress Presentation
Multi-imaging characterisation of cardiac phenotype in different types of amyloidosis
29 August 2022
thumbnail
Congress Presentation
Exploring ATTR cardiomyopathy: the journey to improved outcomes
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources